[Federal Register: June 21, 2006 (Volume 71, Number 119)]
[Notices]              
[Page 35610]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21jn06-47]                        

-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Docket 26-2006]

Foreign-Trade Zone 231--Stockton, CA, Application for Subzone
Status, Medline Industries, Inc., (Medical Supply Distribution)

    An application has been submitted to the Foreign-Trade Zones Board
(the Board) by the Port of Stockton, grantee of FTZ 231, requesting
special-purpose subzone status for the medical supply distribution
facility of Medline Industries, Inc., located in Lathrop, California.
The application was submitted pursuant to the provisions of the
Foreign-Trade Zones Act, as amended (19 U.S.C. 81a-81u), and the
regulations of the Board (15 CFR part 400). It was formally filed on
June 15, 2006.
    The Medline facility (277,200 sq. ft./12.49 acres/30 employees) is
located at 18250 Murphy Parkway, Lathrop, California. The facility is
used for warehousing and distribution of foreign-origin and domestic
medical supplies for the U.S. market and export. FTZ procedures would
be utilized to support Medline's import and domestic distribution
activity. Finished medical supplies to be admitted to the proposed
subzone for distribution would include: medical gloves of natural
rubber, surgical/medical gloves of plastic, apparel items of cotton and

man-made fibers (gowns, shirts, overalls, caps, baby shirts, scrubs,
covers, socks, pajamas, slippers), woven/non-woven bed linens, towels,
pillows, diapers, aprons, canes, walkers, wheelchairs, scooters, grab
bars, beds, commodes, wooden bedroom furniture, folios, leather and
man-made fiber travel bags, thermometers, vacuum pumps, watch cases,
and toiletry items. The application states that all quota-class textile
and apparel products classified under Textile Import Quota categories
would be admitted to the proposed subzone under domestic (duty-paid)
status (19 CFR Sec.  146.43), and any products subject to antidumping
duties would be admitted under domestic (duty-paid) or privileged
foreign status (19 CFR Sec.  146.41).
    FTZ procedures would exempt Medline from Customs duty payments on
foreign products that are re-exported. On domestic sales, the company
would be able to defer payments until merchandise is shipped from the
facility and entered for U.S. consumption. Medline also plans to
utilize certain logistical benefits that will help facilitate the

distribution of domestic and foreign merchandise in a consolidated
manner. The application indicates that all of the above-cited savings
from FTZ procedures would help improve the facility's international
competitiveness.
    In accordance with the Board's regulations, a member of the FTZ
Staff has been designated examiner to investigate the application and
report to the Board.
    Public comment is invited from interested parties. Submissions
(original and 3 copies) shall be addressed to the Board's Executive
Secretary at the address below. The closing period for their receipt is
August 21, 2006. Rebuttal comments in response to material submitted
during the foregoing period may be submitted during the subsequent 15-
day period to September 5, 2006.
    A copy of the application and accompanying exhibits will be
available for public inspection at each of the following locations:
U.S. Department of Commerce Export Assistance Center, 1301 Clay Street,
Oakland Federal Building North Tower, Suite 630N, Oakland, California

94612; and, Office of the Executive Secretary, Foreign-Trade Zones
Board, Room 1115, U.S. Department of Commerce, 1401 Constitution
Avenue, NW, Washington, District of Columbia 20230-0002; Tel: (202)
482-2862.

    Dated: June 15, 2006.
Pierre V. Duy,
Acting Executive Secretary.
[FR Doc. E6-9799 Filed 6-20-06; 8:45 am]
BILLING CODE 3510-DS-S